UIM3:XETRA:XETRA-UBS ETF SICAV - FTSE 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 89.93

Change

-1.11 (-1.22)%

Market Cap

USD 0.07B

Volume

64.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.02%)

USD 420.85B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.08%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.09%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.02 (-0.07%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.35%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 102.32B
8R80:XETRA Amundi Index Solutions - Amund..

+0.18 (+0.13%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.06 (-0.12%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.50 (-0.50%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.84 (-0.32%)

USD 80.38B

ETFs Containing UIM3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.60% 51% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.60% 52% F 55% F
Trailing 12 Months  
Capital Gain 14.99% 45% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.99% 45% F 50% F
Trailing 5 Years  
Capital Gain 13.89% 41% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.89% 41% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 6.78% 55% F 55% F
Dividend Return 8.39% 62% D 60% D-
Total Return 1.61% 84% B 62% D
Risk Return Profile  
Volatility (Standard Deviation) 11.73% 53% F 62% D
Risk Adjusted Return 71.49% 69% C- 72% C
Market Capitalization 0.07B 25% F 23% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.